IL37 and hepatocellular carcinoma: Furthermore, in an HCC transplantation model in vivo, the inoculation of IL-37-transfected TAMs into recipients resulted in a substantial reduction in tumour growth compared to mice without IL-37 transfection (43), providing additional confirmation of the anti-tumour function of IL-37.